SlideShare uma empresa Scribd logo
1 de 136
Toxicology of the Erythron
Dr R B Cope BVSc BSc(Hon 1) PhD cGLPCP DABT ERT
Learning Objectives
• To understand the key basic functional concepts of the
  erythron;

• To understand the fundamentals of erythrokinetics;

• To understand and accurately interpret changes in erythrocyte
  physical parameters (PCV/hematocrit, MCH, MCHC, MCV);

• To understand and accurately interpret changes to
  erythrocyte morphology;

• To understand and accurately recognize common abnormal
  changes in the erythron.
Basic Concepts of Erythrocyte Function
• The erythron:
   – Consists of circulating erythrocytes + bone marrow
     precursors + bone marrow progenitor centers + stem cells;

   – Key function is oxygen transport mediated by hemoglobin;
Basic Concepts of Erythrocyte Function: Heme Synthesis

                                Disruption of heme synthesis will result
                                in prophyrias due to the accumulation
                                of heme precursors or catabolites.

                                Porphyrias are most commonly genetic
                                (heritable) disorders of
                                metabolism, however xenobiotic-
                                induced porphyrias (or exacerbation of
                                inherited porphyrias) may also occur
                                (common: e.g. lead inhibits
                                ferrochetalase).

                                Porphyrias may or may not be
                                associated with anemia depending on
                                which part of the heme cycle is
                                disrupted.

                                The most common cause (in humans)
                                of reduced heme synthesis is iron
                                deficiencies.
Basic Concepts of Erythrocyte Function: Globin Synthesis




The switch from fetal to adult Hb varies considerably across species. In normal humans, fetal
Hb is present until about 8 months of life. In normal adult humans ~ 97% of Hb is HbA, ~ 3% is
HbA2. The types of Hb present in adults varies across species
Note: Fe is in the Fe2+ in the majority of Hb under normal conditions
Porphyrias
• Supplementary reading:
   – http://emedicine.medscape.com/article/1389981-
     overview

   – Xenobiotic-induced porphyria cutanea tarda is the only
     one I have personally come across:

   http://emedicine.medscape.com/article/1103643-overview
Conditions Affecting Oxygen Carrying Capacity:
                Oxygen Hb Dissociation Curves




• Fetal Hb has a higher affinity for O2 than normal adult Hb – lower oxygen delivery to the
  tissues compared with adults
Conditions Affecting Oxygen Carrying Capacity:
        Oxygen Hb Dissociation Curves
Conditions Affecting Oxygen Carrying Capacity:
                Oxygen Hb Dissociation Curves




  2,3-DPG = 2,3-diphosphoglycerate

• Remember:
   • Left shift = less oxygen to the tissues = tissue hypoxia
   • Right shift = more oxygen to the tissues
Conditions Affecting Oxygen Carrying Capacity:
             Oxygen Hb Dissociation Curves
• Common and important toxicological situations affecting the
  O2Hb dissociation curve include:

   – Oxidative attack on erythrocytes and
     methemoglobinemias

   – Formation of sulfhemaglobin

   – Carbon monoxide
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – Common cause of toxicological insult to the erythron

  – The presence of Fe in the Fe2+ reduction state is critical for
    normal O2 carrying capacity

  – Any oxidizing agent has the capacity to produce metHb by
    oxidizing Hb Fe2+ to Hb Fe3+ (ferrous  ferric)
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – The critical effect of metHb is decreased tissue oxygen
    supply (i.e. tissue hypoxia)

  – MetHb cannot bind oxygen

  – The presence of metHb results in a left shift of the O2Hb
    dissociation curve, further exacerbating tissue hypoxia
• Blood and mucous membranes are discolored brown (“muddy”)
• Blood color change does not reverse (or reverses slowly) with exposure to
  oxygen (i.e. bubbling oxygen through tube of blood)
Hemolysis and other signs of oxidative erythrocyte injury are
commonly present (e.g. Heinz bodies, intravascular hemolysis)
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – Note: Rodents are notoriously resistant to oxidative
    damage to the erythron and the formation of metHb

  – Note: Routine rodent studies alone may not detect the
    propensity for metHb formation and/or oxidative damage
    to the erythron

  – Note: Children under 4 years of age are more susceptible
    to oxidative damage to the erythron

  – Note: Cats are notoriously susceptible to oxidative damage
    to the erythron
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – Note: in some human subpopulations glucose-6-
    phosphate dehydrogenase deficiency common (typically
    people of African, Middle Eastern and South Asian descent
    – protective adaptation to endemic malaria). These
    subpopulations are highly susceptible to oxidative assault
    on the erythron
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – Note: Persons with pyruvate kinase deficiency are highly
    susceptible to oxidative damage to the erythron (lower
    energy generation  lower capacity to recycle GSH)
     • Also increases 2,3-bisphosphoglycerate (2,3 BPG)  right shift of
       the O2Hb dissociation curve  increased tissue oxygenation 
       individuals with PK deficiency may have a greater capacity for
       physical activity than others with similarly low hemoglobin levels.


  – Note: Persons with cytochrome b5 reductase deficiency
    are highly susceptible to oxidative damage to the erythron
    (reduced capacity to reverse metHb)
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Methemoglobinemia

  – Note: Any organo-amine compound should be suspected
    of being a cause of oxidative damage to the erythron until
    proven otherwise

  – Note: any nitrite or nitrate compound (or compounds that
    are metabolized to a nitrite or a nitrate) are similarly
    suspect

  – Note: chromates are also similarly suspect

  – Note: Halogenated benzenes are also similarly suspect
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Sulfhemoglobinemia

   – Due to the formation of ferric sulfide in Hb

   – Cannot be reversed metabolically – requires the
     replacement of affected erythrocytes

   – Produces a right shift of the O2Hb dissociation curve

      • Question: does this make tissue oxygenation better or
        worse?
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• Sulfhemoglobinemia

   – Usually drug induced
      • Drugs associated with sulfhemoglobinemia include
        acetanilid, phenacetin, nitrates, trinitrotoluene and
        sulfur compounds (mainly
        sulphonamides, sulfasalazine)

   – Occupational exposure to sulfur compounds is another
     potential cause

   – > 0.5 g% sulfHb is abnormal
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• CO-Hb; carbon monoxide poisoning; carboxy-Hb

   – Can occur due to either inhalation of CO (notably products
     of incomplete combustion) or xenobiotics that are
     metabolized to CO (common example is methylene
     chloride)

   – Hemoglobin binds to carbon monoxide preferentially
     compared to oxygen (approx 240:1)

   – COHb will not release the carbon monoxide, and therefore
     hemoglobin will not be available to transport oxygen from
     the lungs to the rest of the body
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• CO-Hb; carbon monoxide poisoning; carboxy-Hb

   – COHb has a half-life in the blood of 4 to 6 hours

   – T½ reduced by exposure to oxygen

   – COHb increases the risk of infarction (increased incidence
     of ischemic disease in users of methylene chloride)

   – Produces a left shift of the O2Hb dissociation curve

      • Question: does this make tissue oxygenation better or
        worse?
Conditions Affecting Oxygen Carrying Capacity:
             Oxygen Hb Dissociation Curves
• CO-Hb; carbon monoxide poisoning; carboxy-Hb

   – Produces a distinctive “cherry red” discoloration of
     blood, tissues, skin

   – Skeletal muscle is notably bright red due to the formation
     of carboxymyoglobin (used commercially to keep meat red
     and more attractive)

   – Persons who have died from CO poisoning are described as
     looking rosy cheeked and healthy (cherry red means dead)
Conditions Affecting Oxygen Carrying Capacity:
            Oxygen Hb Dissociation Curves
• CO-Hb; carbon monoxide poisoning; carboxy-Hb

   – Important issues:
      • Samples must be collected in air-tight tubes
      • Samples must be analyzed quickly otherwise falsely low
        levels of COHb may be detected
      • “Cherry red” discoloration of blood, skin, tissues etc.
        fades with time – important diagnostically
      • Bubbling oxygen through a tube of blood will hasten
        the loss of discoloration – used diagnostically
Basic Concepts of Erythrocyte Function: Iron Metabolism




• Except for external blood loss, there is no normal mechanism for the excretion of iron;
• Provided the enterothelium remains intact, iron absorption is highly regulated;
• Under normal circumstances, there is little free iron present in plasma (total iron binding
  capacity is not saturated)
• Transferrin is a gamma-globulin
Basic Concepts of Erythrocyte Function: Iron Metabolism




• A wide variety of divalent metals compete with Fe2+ for uptake by DMT-1 (notably
  Cd2+, Pb2+);
• The pH of the small intestine favors the formation of Fe3+ (mostly insoluble) which must
  be reduced by Dcytb to Fe2+ (soluble) for absorption to occur.
Basic Concepts of Erythrocyte Function: Iron Metabolism




• Hepcidin is the key hormone regulating Fe uptake from the GI;
• Increased hepcidin occurs in a wide variety of chronic disease states (carcinogenesis) or
  inflammatory diseases leading to “anemia of chronic disease.”
• Anemia of chronic disease is a common finding in chronic toxicology studies.
Measures of Iron Status: Serum Iron


• Measures the amount of iron bound to transferrin in the
  serum

• Unreliable as a measure of total body iron stores

• Can be reported as a % of total iron binding capacity (see
  later)
Measures of Iron Status: Serum Iron

• Conditions associated with low SI
   – Iron deficiency
   – Acute and chronic inflammatory processes/disease
     (anemia of chronic disease, anemia of inflammatory
     disease)
   – Hypoproteinemia (notably advanced liver disease)s
   – Hypothyroidism
   – Renal disease
Measures of Iron Status: Serum Iron

• Conditions associated with high SI
   – Hemolytic anemia (due to release of Fe from destroyed
     erythrocytes)
   – Sampling error resulting in hemolysis
   – Excessive glucocorticoids in some species (e.g. Cushing’s
     disease)
   – Iron overload
      • Acquired – Fe overload (Fe poisoning, excessive
        transfusions etc.)
      • Hereditary
   – Non-regenerative anemias (decreased Fe utilization)
Measures of Iron Status: Serum Total Iron Binding Capacity
 • TIBC is an indirect measure of how much Fe the transferring
   present in serum will bind

 • Under normal conditions, about ⅓ of transferring binding sites
   are occupied under normal conditions – serum transferrin is
   not saturated under normal conditions

 • The difference between TIBC and SI is the amount of available
   Fe-binding capacity = unbound iron-binding capacity
Measures of Iron Status: Serum Total Iron Binding Capacity

 • TIBC is increased in Fe deficiency in most species

 • TIBC is reduced (or even saturated [i.e. UIBC = 0]) in:
    – Fe poisoning
    – Intravascular hemolysis
    – Sampling error (hemolysis)
Measures of Iron Status: Ferritin

• Ferritin represent the labile (i.e. rapidly available) storage
  form of Fe

• Small amounts of ferritin are normally present in the
  circulation as part of normal Fe homeostasis

• Serum ferritin is decreased during iron deficiency
Measures of Iron Status: Ferritin

• Serum ferritin is increased during:
   – Hemolytic anemia
   – Iron overload
   – Acute and chronic inflammation
   – Liver disease
   – Neoplasia (notably lymphoma)
   – Malnutrition
Common Causes of Disruptions of Iron Status in Repeated
              Dose Toxicology Studies
• Iron deficiency and/or reduced iron uptake

    – More likely to be seen in chronic studies

    – Early stages may occasionally be seen in sub-chronic studies

    – In rodent studies, the animals are relatively young at the start of
      the study and are still rapidly growing (increased iron
      requirement + reduce capacity to absorb it from the GI + higher
      Hb turnover associated with switch from HbF to HbA)

    – Iron deficiencies can also can result when high concentrations of
      the test article are used in the diet – dietary dilution of essential
      minerals
Common Causes of Disruptions of Iron Status in Repeated
              Dose Toxicology Studies

• Iron deficiency and/or reduced iron uptake

    – Test article either inhibits or is a competitive substrate for
      enterothelial DMT-1 (typically other divalent metals) or
      Dcytb

    – Test article is an inhibitor of or competitor ferroportin

    – Test article reduced dietary iron bioavailability (binding in
      gut  insoluble) e.g. starches, tanins, phytates, vit. C, etc..
Common Causes of Disruptions of Iron Status in Repeated
              Dose Toxicology Studies

• Chronic disease states, notably neoplasia (increased hepcidin)

• Significant inflammatory diseases (acute or chronic; increased
  hepcidin)

• Hemolysis (error or due to toxicological effects)

• Severe liver disease
Erythrokinetics




                  Essential for RBC production:

                  •   Iron
                  •   Vitamin B12 (cobalamin)
                  •   Folic Acid
Erythrokinetics
• The cell is released from the bone marrow as a reticulocyte
   – Circulating red blood cells are ~1% reticulocytes
   – After 1–2 days these ultimately become "erythrocytes" or mature red
     blood cells


   Question: what does it mean if you have an increased % of
   reticulocytes in the peripheral blood?

   Question: what does it mean if you have an increased % of
   normoblasts or nucleated RBCs in the peripheral blood?
Erythrokinetics

• The following characteristics can be seen changing in the
  erythrocytes when they are maturing:
   – They show a reduction in the cell size;
   – The cytoplasmic matrix increases in amount;
   – Staining (Wright’s stain) reaction of the cytoplasm changes from blue
     to pinkish red (this is because of the decrease in the amount of RNA
     and DNA);
   – Initially the nucleus was large in size and contained open chromatin.
     But with the maturation of RBC's the size of the nucleus decreases and
     finally disappears with the condensation of the chromatin material.


Question: what does it mean if you have an increase in the
number of RBCs in the peripheral circulation that stain blue
(technical term = polychromasia or polychromatophilia)?
Erythrokinetics




Question: what does it mean if you have an increase in variation
of erythrocyte size in peripheral blood (technical term =
anisocytosis)?
Erythrokinetics
• Lifespan of an RBC in peripheral blood is species specific – in
  the range of 70 – 150 days in mammals depending on species;
  35 days or so in birds

• Eryptosis (RBC programmed cell death)
   – Form of apoptosis
   – Process makes the RBC prone to the extravascular pathway
     of erythrocyte destruction (phagocytosis by the
     reticuloendothelial systems of the liver, spleen and bone
     marrow [predominantly the red pulp of the spleen])
   – Normally eryptosis and erthyropoesis exist in balance
Erythrokinetics
• Two pathways for RBC destruction:

   – Extravascular pathway (predominantly in the spleen, but also bone
     marrow and liver)

   – Intravascular pathway (i.e. lyse within the circulation)
The anatomic structure of the spleen is ideal for testing the metabolic machinery and
pliability of the red blood cells. Within the splenic pulp, red blood cells are concentrated
and their intracellular metabolic pathways stressed. Following this, red blood cells must
pass through 2- to 5-µm pores to enter the sinusoidal system. Unusually rigid cells or a
cell containing inclusion bodies will be unable to pass this test and will be destroyed by
sinusoidal reticuloendothelial cells.
Bite Cell
Regulation of Erythropoesis




EPO is produced in the juxtaglomerular apparatus of the kidney
Evaluation of the Erythron:
           Indicators of the Circulating RBC Mass
• Endpoints that are commonly used are:

   – Hematocrit (= packed cell volume = PCV)

   – Hemoglobin concentration of peripheral blood

   – RBC count
Evaluation of the Erythron: Hematocrit
     (Packed Cell Volume = PCV)
Evaluation of the Erythron: Hematocrit
            (=HCT=Packed Cell Volume = PCV)
• HCT measured by centrifugation is a very accurate measure (±
  1%)

• Most commonly HCT is a calculated value from automated cell
  counters where HCT% = RBC/ul x mean corpuscular volume
  (fL)

   – Calculated HCT has a higher level of error

   – Cell counter MUST be calibrated to the species being
     examined

   – Birds have eliptical nucleated RBCs which interferes with
     this method
Evaluation of the Erythron: Hematocrit
              (=HCT=Packed Cell Volume = PCV)

• Typically plasma protein concentration by refractometry is
  measured at the same time

• Typically the plasma color is examined (red for
  hemolysis, yellow of icterus/jaundice, lipidemia = pink and
  opaque)
Evaluation of the Erythron: Hb Concentration
• Provides the most direct measurement of the oxygen
  transport capacity of blood

• Value should be ~ ⅓ of the HCT if RBCs are of normal size

• Typically a colorimetric measurement

• Must be corrected if Heinz bodies, hemolysis, or lipidemia is
  present

• Major advantage over HCT is it allows calculation of the MCH
  and MCHC
Evaluation of the Erythron: RBC Count
• Automated machine counting is reasonably accurate if
  appropriately calibrated (except for birds)

• Manual hemocytometer counts have a large error and are of
  little value except in birds

• Major value of RBC count is that it allows calculation of the
  MCV and MCH (see below)
Evaluation of the Erythron: RBC Count

• Low values occur in anemia

• High values occur in polycythemia (or blood doping)

• Spuriously high values occur with dehydration and excitement
  in species with a contractile spleen (notably horses)
Evaluation of the Erythron:
                 Factors Affecting HCT, Hb, RBC

• Low values occur in anemia

• High values occur in polycythemia (or blood doping)

• Spuriously high values occur with dehydration and excitement
  in species with a contractile spleen (notably horses)

• Overhydration will result in spuriously low values

• Fluid shifts (e.g. shock) can cause spurious values
Evaluation of the Erythron:
                 Factors Affecting HCT, Hb, RBC
• The hydration/intravascular volume status of the animal must be
  determined in order to accurately interpret HCT, Hb and RBC!

• How do you do this?

   – Total serum or plasma protein (serum or plasma specific gravity)
     in combination with the albumen:globulin ratio (A:G) is a useful
     quick guide

   – If the TP and plasma albumen are increased (in proportion) and
     the A:G ratio remains within the normal range, this is an
     indicator of dehydration (particularly if combined with an
     increased HCT HB & RBC)

   Why?
Evaluation of the Erythron:
                Factors Affecting HCT, Hb, RBC


• If both the TP and A:G are within the normal range and the
  HCT Hb & RBC are low, what does this suggest?

• If the TP and A:G ratio are within the normal range and the
  HCT Hb & RBC are high, what does this suggest?
Evaluation of the Erythron:
     RBC Indices Used in the Classification of Anemia
• Mean corpuscular volume (MCV) = average RBC volume in fL

• Mean corpuscular hemoglobin (MCH) = average mass of Hb
  present per RBC in pg

• Mean corpuscular hemoglobin concentration (MCHC) =
  average concentration of Hb in RBC in g/100 mL of RBCs

• Red cell distribution width = coefficient of variation of the RBC
  volume distribution
Evaluation of the Erythron:
              Mean Corpuscular Volume (MCV)
• Can be a calculated value or determined by an automated cell
  counter
   – Calculate by dividing the HCT by the RBC count and
     converting to fL
Evaluation of the Erythron:
                Mean Corpuscular Volume (MCV)
• Common causes of increased MCV (macrocytosis)
   – Reticulocytosis – Why?

   – Anything that inhibits nucleic acid synthesis and inhibits cell
     division i.e. reduced number of cell divisions during RBC
     ontogeny in the bone marrow. Commonly B12 deficiency
       • B12 deficiency is classically macrocytic and hypochromic (see later)

   – Anything that delays RBC maturation – Why?

   – Genetics – must make sure you are using the correct normal
     control values for the given strain

   – Spurious – RBC agglutination will result in falsely high MCV
     values
Evaluation of the Erythron:
                 Mean Corpuscular Volume (MCV)
• Common causes of increased MCV (macrocytosis)

   – Megaloblastic anemia, the most common cause of macrocytic
     anemia, is due to a deficiency of either vitamin B12, folic acid, or both

   – Pernicious anemia is caused by a lack of intrinsic factor, which is
     required to absorb vitamin B12 from food. A lack of intrinsic factor
     may arise from an autoimmune condition targeting the parietal cells
     (atrophic gastritis) that produce intrinsic factor or against intrinsic
     factor itself. These lead to poor absorption of vitamin B12. Alcoholism
     is a major cause of B12 malabsorption

   – Macrocytic anemia can also be caused by damage to the stomach
     (reduced B12 and folate absorption)

   – Hypothyroidism

   – Methotrexate, zidovudine, and other drugs may inhibit DNA
     replication.
Evaluation of the Erythron:
           Mean Corpuscular Volume (MCV)
• Common causes of increased MCV (macrocytosis)

   – Macrocytic anemia can be further divided into
     "megaloblastic anemia" or "nonmegaloblastic macrocytic
     anemia".

   – The cause of megaloblastic anemia is primarily a failure of
     DNA synthesis with preserved RNA synthesis, which results
     in restricted cell division of the progenitor cells. The
     megaloblastic anemias often present with neutrophil
     hypersegmentation (six to 10 lobes).

   – The nonmegaloblastic macrocytic anemias have different
     etiologies (i.e. unimpaired DNA globin synthesis,) which
     occur, for example, in alcoholism.
Evaluation of the Erythron:
               Mean Corpuscular Volume (MCV)
• Immature animals of most species have small RBCs and lower
  normal MCV values – must use the correct normal range for
  the species, strain and age group!

• Causes of reduced MCV (microcytosis)
      • Iron deficiency is a classical cause of microcytosis – due
        to an additional round of cell division required to reach
        the critical cytoplasmic concentration of Hb necessary
        to stop further DNA synthesis and cell division of RBC
        precursors. Typically Fe deficiency anemias are
        microcytic hypochromic anemais
Evaluation of the Erythron:
              Mean Corpuscular Volume (MCV)
• Causes of reduced MCV (microcytosis)
   – Heme synthesis defect
      • Iron deficiency anemia
      • Anemia of chronic disease (more commonly presenting
        as normocytic anemia)

   – Globin synthesis defect
      • Alpha-, and beta-thalassemia
      • HbE syndrome
      • HbC syndrome
      • Various other unstable hemoglobin diseases
Evaluation of the Erythron:
             Mean Corpuscular Volume (MCV)
• Normocytic anemias

   – Normocytic anemia occurs when the overall hemoglobin
     levels are decreased, but the red blood cell size (mean
     corpuscular volume) remains normal.

   – Causes include:
      • Acute blood loss
      • Anemia of chronic disease
      • Aplastic anemia (bone marrow failure)
      • Hemolytic anemia
Evaluation of the Erythron:
               Mean Corpuscular Hb (MCH)
• MCH = Hb ÷ RBC count

• Generally factors affecting the MCV affect the MCH in a
  similar way
   – If the MCV is decreased (e.g. Fe deficiency), the MCH
     decreases since smaller RBCs contain less Hb

• In general, the MCH is much less value than the other
  parameters in the classification of anemias

• Interpretation of the Hb status of RBCs should be based on
  the MCHC rather than the MCV because the MCHC corrects
  for cell volume
Evaluation of the Erythron:
      Mean Corpuscular Hb Concentration (MCHC)
• MCHC = Hb ÷ HCT and then adjusted to g/dL

• MCHC is the most accurate of the RBC indices because it does
  not require a RBC count

• MCHC is the most useful parameter in classification of
  anemias

• A true increase in MCHC does not normally occur
   – Increased MCHC is almost always spurious – due to
      hemolysis (calculation assumes that all Hb is contained
      within RBCs which is not true if hemolysis has occurred)
Evaluation of the Erythron:
       Mean Corpuscular Hb Concentration (MCHC)
• Reduced MCHC (Hypochromasia = hypochromia)

   – Occurs with reticulocytosis – reticulocytes are larger cells
     and contain less Hb, accordingly the Hb concentration is
     decreased

   – Iron deficiency due to reduced synthesis of Hb

   – Vitamin B6 deficiency – reduced synthesis of Hb

   – Lead exposure (inhibition of synthesis of Hb)

   – Drugs or xenobiotics that disrupt Hb synthesis
Microcytic hypochromic anemia (Fe deficiency)
Evaluation of the Erythron:
                 RBC Distribution Width (RDW)
• Coeficient of variation of the RBC volume distribution
• RDW = SDMCV ÷ MCV x 100
• Index of the variation in size (i.e. aniocytosis) of RBCs

• Anemias which are microcytic or macrocytic will have
  increased anioscytosis and an increased RDW

• Significant reticulocytosis will result in an increased RDW and
  anisocytosis
Aniosocytosis
Reticulocytosis
Peripheral Blood Smear – RBC Morphology
• Stains
   – New methylene blue – acidic structures stain blue or
     purple (i.e. DNA, RNA, basophil granules)

   – Romanowsky stains (e.g. Wright’s, Diff-Quick) – acidic
     structures stain blue to purple, basic groups stain red
     (protein, eosinophil granules)
Peripheral Blood Smear – RBC Morphology
• Rouleaux formation
   – RBCs for stacks
   – Presence indicates an alteration of RBC surface charge
     (zeta potential)
   – Interpretation depends on the species
       • Horses normally have some Rouleaux formation in
         health
   – Rouleaux formation correlates with the RBC sedimentation
     rate i.e. protein coating of the surface of RBCs (e.g. fibrin
     during inflammatory processes, increased
     globulins, multiple myeloma)  increased ESR + increased
     Rouleaux formation
Peripheral Blood Smear – RBC Morphology
• Agglutination
   – Grape-like congregations of RBCs due to the presence of a
     cross-linking antibody (typically anti RBC IgM)

   – Important in toxicology because there are numerous
     xenobiotics that act as haptens on the surface of RBCs and
     generate an autoimmune anemia
Peripheral Blood Smear – RBC Morphology
• Spherocytes
   – Associated with immune mediated anemias – an important
     biomarker of extravascular immune-mediated RBC
     destruction

   – Result of phagocytosis of antigens on the surface of RBCs

   – Can result from phagocytosis of Heinz bodies (areas of
     oxidative precipitation of Hb in the erythrocyte –
     biomarker of oxidative damage to Hb)

   – Rarely, can result of changes to cell membrane compositon
     (acquired or hereditary)
Peripheral Blood Smear – RBC Morphology
• Polychromatophilia
   – Cells have a light blue-gray color when stained with a
     Wright’s stain

   – Classical feature of increased numbers of immature
     peripheral RBCs in the peripheral blood i.e. accelerated
     release of RBCs from the bone marrow

   – Classical characteristic feature of reticulocytes i.e.
     reticulocytosis is described as macrocytic, polychromasia
     and polychromatophilic..
Peripheral Blood Smear – RBC Morphology
• Poikilocytosis
   – General term for abnormally shaped RBCs
   – Can be spurious due to storage of sample before analysis
   – Can be normal in some species and at some stages of
     development e.g. switching from fetal to adult Hb
   – Indicate trauma to the RBC cell membrane due to
       • Turbulent blood flow
       • Intravascular fibrin (microangiopathic effects)
   – Specific types of poikilocytes can be associated with
     particular diseases e.g. acanthocytes are associated with
     particular types of liver diseases
Acanthocytosis


Typical response to listening to Barry Manilow music…..
Peripheral Blood Smear – RBC Morphology
• Echinocytosis
   – Form of poikiloctyes

   – Can be due to artifact

   – Can be due to xenobiotic exposure, particularly if effected
     blood electrolytes or membrane electrolyte transport or
     osmotic effects
Peripheral Blood Smear – RBC Morphology
• Hemlet cells (keratocytes)
   – Biomarker of oxidative damage to RBCs
   – Develop due to rupturing of a cell membrane vesicle or
     membrane blebs
   – Can also be produced by microangiopathic processes (see
     schistocytes below)
Peripheral Blood Smear – RBC Morphology
• Schistocyte
   – Irregular RBC fragments due to cutting of the RBC into
     pieces by intravascular fibrin deposits
Peripheral Blood Smear – RBC Morphology
• Basophilic stippling
   – Due to residual clumps of RNA, or precipitated ribosomes
     or mitochondria in RBCs

   – A characteristic of lead exposure (rare finding) – typically
     there is basophilic stippling but NO polychromasia (why?)

   – Can occur during regenerative anemias in conjunction with
     polychromasia

   – Also seen with severe burns, some xenobiotics, septicemia
Peripheral Blood Smear – RBC Morphology
• Heinz bodies
   – A classical biomarker of oxidative damage to the erythron
   – Due to denatured Hb
   – RBCs prone to hemolysis
Peripheral Blood Smear – RBC Morphology
• Metarubricyte

   – Term refers to the presence of any form of nucleated RBC
     in the peripheral blood

   – Indicates highly increased demand for RBCs and may be
     appropriate (e.g. response to increased erythropoesis in
     responsive anemias) or inappropriate (e.g. due to lead
     poisoning, Fe deficiency, Cu deficiency etc.)
Bone Marrow Evaluation
• Parameters:
  – Cellularity
  – Number of megakaryocytes (platelet precursors)
  – Myeloid: erythroid ratio
  – Morphology
Bone Marrow Evaluation
• M:E ratio
  – Usually used to determine the efficiency of the response
    to anemia

   – Should be interpreted with the WBC count i.e. if the WBC
     count is normal and the M:E is decreased it is indicative of
     an increased production of RBCs and a normal response to
     anemia

   – A high M:E ratio in the presence of a normal WBC count
     and anemia indicates a problem with RBC production
Regenerative Vs Non-Regenerative Anemias
• Characteristics of regenerative anemias = evidence of
  increased production of RBCs
   – Polychromasia – Why?
   – Reticulocytosis – Why?
   – Anisocytosis + increased RDW – Why?
   – Increased MCV + macrocytosis – Why?
   – Basophilic stippling – Why?
   – Hypercellular bone marrow with a reduced M:E – Why?

   – Are all of the above responses appropriate and if so, why?
Regenerative Vs Non-Regenerative Anemias
• Characteristics of regenerative anemias = evidence of
  increased production of RBCs
   – Polychromasia – Why?
   – Reticulocytosis – Why?
   – Anisocytosis + increased RDW – Why?
   – Increased MCV + macrocytosis – Why?
   – Basophilic stippling – Why?
   – Hypercellular bone marrow with a reduced M:E – Why?

   – Are all of the above responses appropriate and if so, why?
Regenerative Vs Non-Regenerative Anemias
• Characteristics of regenerative anemias

   – Tend to be non-chronic

   – Internal blood loss and hemolytic anemias tend to respond
     more rapidly than external blood loss anemias (why?)
Regenerative Vs Non-Regenerative Anemias
• Characteristics of non-regenerative anemias

   – Tend to chronic – why?

   – By definition there is an inadequate bone marrow response
     which may be due to:
      • Not enough time – RBC destruction is faster than RBC
        production
      • Inadequate precursor materials (e.g. Fe, B12, B6 etc.)
      • Increased hepcidin due to inflammatory diseases (decreased
        Fe)
      • Renal disease – not enough erythropoeitin
      • Bone marrow destruction (neoplasia, infections)
Case Studya1
     • Following data (group mean from treatment group) was
       from day 45 of a 90 day study in rats:
Parameter                       Value           High or low relative to normal Range, Pre-
                                                exposure measurements and control Group (all
                                                changes statistically significant)
HCT                             13 %            Low
Hb                              3.9 g/dL        Low
RBC                             1.59 x 106/ul   Low
MCV                             81 fL           High
MCH                             24.5 pg
MCHC                            30.0 %          Low
Reticulocytes                   16.5 %          High
                                264 x 103/ul
Nucleated RBCs                  3 per 100 WBC   High
Total protein                   3.8 g/dL        Low
Albumin                         1.8 g/dL        Low
A:G                             0.90            Normal
RBC morphology: anisocytosis,
polychromasia
Case Studya1
 • Following data (group mean from treatment group) was
      from day 45 of a 90 day study in rats:


Parameter                  Value           High or Low Compared With Normal
                                           Range and Control Group

Platelets                  653 x 103/uL    High
WBC                        17.5 x 103/uL   High
WBC morphology is normal   1.59 x 106/ul   Low
Case Study 1
• Answer the following questions

   –   What is the type of erythron problem present?
   –   What other problems are present?
   –   What is the likely mechanism involved?
   –   Is the problem being reversed/repaired?
   –   What would you hope to see by day 90 of the study?
   –   What would you expect to see 30 days following the
       cessation of exposure to the test article?
         • Why?
         • What conditions might have to happen for any change
           to occur?
         • What conditions might prevent any putative recovery?
Case Studya2
     • Following data (group mean from treatment group) was
       from day 90 of a rat study
Parameter                       Value           High or low relative to normal Range, Pre-
                                                exposure measurements and control Group (all
                                                changes statistically significant)
HCT                             15%             Low
Hb                              4.4 g/dL        Low
RBC                             1.79 x 106/ul   Low
MCV                             84 fL           High
MCH                             24.6 pg
MCHC                            29.3 %          Low
Reticulocytes                   24 %            High
                                430 x 103/ul
Nucleated RBCs                  6 per 100 WBC   High
Total protein                   6.5 g/dL        Normal
Albumin                         2.9 g/dL        Normal
A:G                             0.81            Normal
RBC morphology: anisocytosis,
polychromasia, spherocytosis,
Case Study 2
• Answer the following questions

   –   What is the type of erythron problem present?
   –   What other problems are present?
   –   What is the likely mechanism involved?
   –   Is the problem being reversed/repaired?
   –   What would you hope to see by day 90 of the study?
   –   What would you expect to see 30 days following the
       cessation of exposure to the test article?
         • Why?
         • What conditions might have to happen for any change
           to occur?
         • What conditions might prevent any putative recovery?
Case Study 3
 • Following data (group mean from a treatment group) was from day 3 of a 90 day
   study in cats. Some deaths have occurred in this exposed group
Parameter                         Value          High or low relative to normal Range, Pre-
                                                 exposure measurements and control Group (all
                                                 changes statistically significant)
HCT                               25.2%          Low
Hb                                11.2 g/dL      Normal
RBC                               5.5 x 106/ul   Low
MCV                               45 fL          Normal
MCH                               20 pg
MCHC                              44 %           High
Total protein                     8.5            High
Albumin                           3.9 g/dL       Normal
A:G                               0.85           Normal
RBC morphology: excessive Heinz
bodies present
Additional comments: serum is
red tinged, blood was chocolate
colored, urine was dark brown
Case Study 3
• Answer the following questions

   –   What is the type of erythron problem present?
   –   What other problems are present?
   –   What is the likely mechanism involved?
   –   Is the problem being reversed/repaired?
   –   What other problems might occur with this?
   –   What would you hope to see by day 90 of the study?
   –   What would you expect to see 30 days following the
       cessation of exposure to the test article?
         • Why?
         • What conditions might have to happen for any change
           to occur?
         • What conditions might prevent any putative recovery?
Case Studya4
     • Following data (group mean from treatment group) was
       from day 90 of a 90 day study in rats:
Parameter                       Value           High or low relative to normal Range, Pre-
                                                exposure measurements and control Group (all
                                                changes statistically significant)
HCT                             12.8 %          Low
Hb                              4.0 g/dL        Low
RBC                             2.25 x 106/ul   Low
MCV                             56.9 fL         High
MCH                             17.8 pg         Low
MCHC                            31.3 %          Low
Reticulocytes                   0%              Low
Nucleated RBCs                  0 per 100 WBC   High
RBC morphology: hypochromasia
Case Study 4
• Answer the following questions

   –   What is the type of erythron problem present?
   –   What other problems are present?
   –   What is the likely mechanism involved?
   –   Is the problem being reversed/repaired?
   –   What other problems might occur with this?
   –   What would you hope to see by day 90 of the study?
   –   What would you expect to see 30 days following the
       cessation of exposure to the test article?
         • Why?
         • What conditions might have to happen for any change
           to occur?
         • What conditions might prevent any putative recovery?
Case Studya5
     • Following data (group mean from treatment group) was
       from day 90 of a 90 day study in rats:
Parameter                  Value           High or low relative to normal Range, Pre-
                                           exposure measurements and control Group (all
                                           changes statistically significant)
HCT                        26 %            Low
Hb                         8.8 g/dL        Low
RBC                        5.23 x 106/ul   Low
MCV                        49.7 fL         Normal
MCH                        16.8 pg
MCHC                       33.8 %          Normal
Reticulocytes              0.1 %           Normal
                           52 x 103/ul
Nucleated RBCs             0 per 100 WBC   High
Total protein              9.3 g/dL        High
Albumin                    1.9 g/dL        Low
A:G                        0.0.26          low
RBC morphology: Normal
Case Study 5
• Answer the following questions

   –   What is the type of erythron problem present?
   –   What other problems are present?
   –   What is the likely mechanism involved?
   –   Is the problem being reversed/repaired?
   –   What other problems might occur with this?
   –   What would you hope to see by day 90 of the study?
   –   What would you expect to see 30 days following the
       cessation of exposure to the test article?
         • Why?
         • What conditions might have to happen for any change
           to occur?
         • What conditions might prevent any putative recovery?
Case Study 1
• Regenerative blood loss anemia
• Macrocytic hypochromic anemia with polychromasia and
  reticulocytosis
• Loss of total protein due to hemorrhage + subsequent fluid
  shifts into the vascular compartment
Case Study 2
• Macrocytic hypochromic regenerative hemolytic anemia with
  evidence of extravascular erythrophagocytosis
• Autoimmune mediated anemia
Case Study 3
• Oxidative intravascular hemolytic anemia + met Hb
Case Study 4
• Microcytic, hypochromic non-regenerative anemia
• Fe deficiency
Case Study 5
• Normocytic, normochromic anemia + hyperproteinemia due
  increased globulins + decreased albumen
• Chronic inflammatory disease

Mais conteúdo relacionado

Mais procurados

Hemoglobinopathies
Hemoglobinopathies Hemoglobinopathies
Hemoglobinopathies Rakesh Verma
 
Biochem Isoenzymes.ppt
Biochem Isoenzymes.pptBiochem Isoenzymes.ppt
Biochem Isoenzymes.pptRinaDas9
 
RAPAPORT-LEUBERING CYCLE
RAPAPORT-LEUBERING CYCLERAPAPORT-LEUBERING CYCLE
RAPAPORT-LEUBERING CYCLEYESANNA
 
Final lysosomal storage diseases2
Final lysosomal storage diseases2Final lysosomal storage diseases2
Final lysosomal storage diseases2Anupam Singh
 
8 fatty liver and lipotropic factors
8 fatty liver and lipotropic factors8 fatty liver and lipotropic factors
8 fatty liver and lipotropic factorsDhiraj Trivedi
 
Gluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceGluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceNamrata Chhabra
 
Metabolism of cholesterol -
Metabolism of cholesterol - Metabolism of cholesterol -
Metabolism of cholesterol - Ashok Katta
 
ALCOHOL METABOLISM
ALCOHOL METABOLISMALCOHOL METABOLISM
ALCOHOL METABOLISMYESANNA
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesPradeep Singh Narwat
 
classification of hormones.pptx
classification of hormones.pptxclassification of hormones.pptx
classification of hormones.pptxExploreLifeScience
 
UREA CYCLE
UREA CYCLEUREA CYCLE
UREA CYCLEYESANNA
 
GLYCINE METABOLISM
GLYCINE METABOLISMGLYCINE METABOLISM
GLYCINE METABOLISMYESANNA
 
Fatty liver biochemistry by Dr. Anurag Yadav
Fatty liver biochemistry by Dr. Anurag YadavFatty liver biochemistry by Dr. Anurag Yadav
Fatty liver biochemistry by Dr. Anurag YadavDr Anurag Yadav
 
HMP SHUNT PATHWAY
HMP SHUNT PATHWAYHMP SHUNT PATHWAY
HMP SHUNT PATHWAYYESANNA
 

Mais procurados (20)

Hemoglobinopathies
Hemoglobinopathies Hemoglobinopathies
Hemoglobinopathies
 
Biochem Isoenzymes.ppt
Biochem Isoenzymes.pptBiochem Isoenzymes.ppt
Biochem Isoenzymes.ppt
 
RAPAPORT-LEUBERING CYCLE
RAPAPORT-LEUBERING CYCLERAPAPORT-LEUBERING CYCLE
RAPAPORT-LEUBERING CYCLE
 
Final lysosomal storage diseases2
Final lysosomal storage diseases2Final lysosomal storage diseases2
Final lysosomal storage diseases2
 
Fatty acid synthesis
Fatty acid synthesisFatty acid synthesis
Fatty acid synthesis
 
Iron metabolism
Iron metabolismIron metabolism
Iron metabolism
 
Carbohydrate metabolism
Carbohydrate metabolismCarbohydrate metabolism
Carbohydrate metabolism
 
8 fatty liver and lipotropic factors
8 fatty liver and lipotropic factors8 fatty liver and lipotropic factors
8 fatty liver and lipotropic factors
 
Gluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significanceGluconeogenesis- Steps, Regulation and clinical significance
Gluconeogenesis- Steps, Regulation and clinical significance
 
Metabolism of cholesterol -
Metabolism of cholesterol - Metabolism of cholesterol -
Metabolism of cholesterol -
 
Ketogenesis
KetogenesisKetogenesis
Ketogenesis
 
ALCOHOL METABOLISM
ALCOHOL METABOLISMALCOHOL METABOLISM
ALCOHOL METABOLISM
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
 
classification of hormones.pptx
classification of hormones.pptxclassification of hormones.pptx
classification of hormones.pptx
 
Cori's cycle
Cori's cycleCori's cycle
Cori's cycle
 
UREA CYCLE
UREA CYCLEUREA CYCLE
UREA CYCLE
 
GLYCINE METABOLISM
GLYCINE METABOLISMGLYCINE METABOLISM
GLYCINE METABOLISM
 
Heme synthesis and porphyrias
Heme synthesis and porphyriasHeme synthesis and porphyrias
Heme synthesis and porphyrias
 
Fatty liver biochemistry by Dr. Anurag Yadav
Fatty liver biochemistry by Dr. Anurag YadavFatty liver biochemistry by Dr. Anurag Yadav
Fatty liver biochemistry by Dr. Anurag Yadav
 
HMP SHUNT PATHWAY
HMP SHUNT PATHWAYHMP SHUNT PATHWAY
HMP SHUNT PATHWAY
 

Destaque

Proximal renal tubule physiology
Proximal renal tubule physiology Proximal renal tubule physiology
Proximal renal tubule physiology Ahad Lodhi
 

Destaque (20)

Rbc
RbcRbc
Rbc
 
35 Lecture Ppt
35 Lecture Ppt35 Lecture Ppt
35 Lecture Ppt
 
Growth body weight-feed
Growth body weight-feedGrowth body weight-feed
Growth body weight-feed
 
Ttc cope 2
Ttc cope 2Ttc cope 2
Ttc cope 2
 
Uof q2011final
Uof q2011finalUof q2011final
Uof q2011final
 
Stomach liver tumors-journal_club
Stomach liver tumors-journal_clubStomach liver tumors-journal_club
Stomach liver tumors-journal_club
 
Thyroid
ThyroidThyroid
Thyroid
 
Nicnas carcinogenesis9
Nicnas carcinogenesis9Nicnas carcinogenesis9
Nicnas carcinogenesis9
 
Jc liver tumors
Jc liver tumorsJc liver tumors
Jc liver tumors
 
Role of toxicology in regulatory processes 1
Role of toxicology in regulatory processes 1Role of toxicology in regulatory processes 1
Role of toxicology in regulatory processes 1
 
Renal nicnas-2012
Renal nicnas-2012Renal nicnas-2012
Renal nicnas-2012
 
The leukon
The leukonThe leukon
The leukon
 
Fabry Disease Urinary Podocyte Loss - 14 February 2014
Fabry Disease Urinary Podocyte Loss - 14 February 2014Fabry Disease Urinary Podocyte Loss - 14 February 2014
Fabry Disease Urinary Podocyte Loss - 14 February 2014
 
Proximal renal tubule physiology
Proximal renal tubule physiology Proximal renal tubule physiology
Proximal renal tubule physiology
 
Fiber toxicology
Fiber toxicologyFiber toxicology
Fiber toxicology
 
Tribal directory 2014
Tribal directory 2014 Tribal directory 2014
Tribal directory 2014
 
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p... Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 
Nicnas gen tox3
Nicnas gen tox3Nicnas gen tox3
Nicnas gen tox3
 
Liver nicnas-nov-2012
Liver nicnas-nov-2012Liver nicnas-nov-2012
Liver nicnas-nov-2012
 
Renal nicnas-2012 copy
Renal nicnas-2012 copyRenal nicnas-2012 copy
Renal nicnas-2012 copy
 

Semelhante a The erythron

hemoglobin and myoglobin (1).pptx
hemoglobin and myoglobin (1).pptxhemoglobin and myoglobin (1).pptx
hemoglobin and myoglobin (1).pptxDrThangarajMD
 
Hemoglobin and myoglobin are two important proteins involved in the transport...
Hemoglobin and myoglobin are two important proteins involved in the transport...Hemoglobin and myoglobin are two important proteins involved in the transport...
Hemoglobin and myoglobin are two important proteins involved in the transport...tekalignpawulose09
 
Week6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationWeek6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationpetshelter54
 
physiology of blood
 physiology of blood physiology of blood
physiology of bloodSabbir Prince
 
Heme Structure. synthesis and porphyrias
 Heme Structure. synthesis and porphyrias  Heme Structure. synthesis and porphyrias
Heme Structure. synthesis and porphyrias Ravi Kiran
 
Blood physiology: Part I
Blood physiology: Part IBlood physiology: Part I
Blood physiology: Part IFawaz A.M.
 
hemoglobin-lab-presentation.pptx
hemoglobin-lab-presentation.pptxhemoglobin-lab-presentation.pptx
hemoglobin-lab-presentation.pptxAshrafiAli
 
HEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESHEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESYESANNA
 
HEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESHEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESYESANNA
 
Protein Function - General Biology 2 Lesson
Protein Function - General Biology 2 LessonProtein Function - General Biology 2 Lesson
Protein Function - General Biology 2 LessonCyrusEsguerra6
 
Hemoglobin and myoglobin
Hemoglobin and myoglobinHemoglobin and myoglobin
Hemoglobin and myoglobinVarinderKhepar
 
Hplc interpretation
Hplc interpretationHplc interpretation
Hplc interpretationMANISHARAJ15
 
The red blood_corpuscles_(r.b.c.s)
The red blood_corpuscles_(r.b.c.s)The red blood_corpuscles_(r.b.c.s)
The red blood_corpuscles_(r.b.c.s)zulujunior
 
porphyrins chemistry and metabolism.pptx
porphyrins chemistry and metabolism.pptxporphyrins chemistry and metabolism.pptx
porphyrins chemistry and metabolism.pptxShahzebHUSSAIN5
 

Semelhante a The erythron (20)

hemoglobin and myoglobin (1).pptx
hemoglobin and myoglobin (1).pptxhemoglobin and myoglobin (1).pptx
hemoglobin and myoglobin (1).pptx
 
Hemoglobin and myoglobin are two important proteins involved in the transport...
Hemoglobin and myoglobin are two important proteins involved in the transport...Hemoglobin and myoglobin are two important proteins involved in the transport...
Hemoglobin and myoglobin are two important proteins involved in the transport...
 
Week6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationWeek6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formation
 
physiology of blood
 physiology of blood physiology of blood
physiology of blood
 
Heme Structure. synthesis and porphyrias
 Heme Structure. synthesis and porphyrias  Heme Structure. synthesis and porphyrias
Heme Structure. synthesis and porphyrias
 
Blood physiology: Part I
Blood physiology: Part IBlood physiology: Part I
Blood physiology: Part I
 
hemoglobin-lab-presentation.pptx
hemoglobin-lab-presentation.pptxhemoglobin-lab-presentation.pptx
hemoglobin-lab-presentation.pptx
 
Haemoglobin
HaemoglobinHaemoglobin
Haemoglobin
 
HEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESHEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVES
 
HEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVESHEMOGLOBIN DERIVATIVES
HEMOGLOBIN DERIVATIVES
 
Protein Function - General Biology 2 Lesson
Protein Function - General Biology 2 LessonProtein Function - General Biology 2 Lesson
Protein Function - General Biology 2 Lesson
 
Hemoglobin and myoglobin
Hemoglobin and myoglobinHemoglobin and myoglobin
Hemoglobin and myoglobin
 
Hemoglobin
HemoglobinHemoglobin
Hemoglobin
 
fish Hemoglobin 17m
fish Hemoglobin 17mfish Hemoglobin 17m
fish Hemoglobin 17m
 
Hplc interpretation
Hplc interpretationHplc interpretation
Hplc interpretation
 
Blood respiratory function & jaundice
Blood respiratory function & jaundiceBlood respiratory function & jaundice
Blood respiratory function & jaundice
 
Hemoglobin 2
Hemoglobin 2Hemoglobin 2
Hemoglobin 2
 
The red blood_corpuscles_(r.b.c.s)
The red blood_corpuscles_(r.b.c.s)The red blood_corpuscles_(r.b.c.s)
The red blood_corpuscles_(r.b.c.s)
 
porphyrins chemistry and metabolism.pptx
porphyrins chemistry and metabolism.pptxporphyrins chemistry and metabolism.pptx
porphyrins chemistry and metabolism.pptx
 
Prb11
Prb11Prb11
Prb11
 

The erythron

  • 1. Toxicology of the Erythron Dr R B Cope BVSc BSc(Hon 1) PhD cGLPCP DABT ERT
  • 2. Learning Objectives • To understand the key basic functional concepts of the erythron; • To understand the fundamentals of erythrokinetics; • To understand and accurately interpret changes in erythrocyte physical parameters (PCV/hematocrit, MCH, MCHC, MCV); • To understand and accurately interpret changes to erythrocyte morphology; • To understand and accurately recognize common abnormal changes in the erythron.
  • 3. Basic Concepts of Erythrocyte Function • The erythron: – Consists of circulating erythrocytes + bone marrow precursors + bone marrow progenitor centers + stem cells; – Key function is oxygen transport mediated by hemoglobin;
  • 4. Basic Concepts of Erythrocyte Function: Heme Synthesis Disruption of heme synthesis will result in prophyrias due to the accumulation of heme precursors or catabolites. Porphyrias are most commonly genetic (heritable) disorders of metabolism, however xenobiotic- induced porphyrias (or exacerbation of inherited porphyrias) may also occur (common: e.g. lead inhibits ferrochetalase). Porphyrias may or may not be associated with anemia depending on which part of the heme cycle is disrupted. The most common cause (in humans) of reduced heme synthesis is iron deficiencies.
  • 5. Basic Concepts of Erythrocyte Function: Globin Synthesis The switch from fetal to adult Hb varies considerably across species. In normal humans, fetal Hb is present until about 8 months of life. In normal adult humans ~ 97% of Hb is HbA, ~ 3% is HbA2. The types of Hb present in adults varies across species
  • 6. Note: Fe is in the Fe2+ in the majority of Hb under normal conditions
  • 7. Porphyrias • Supplementary reading: – http://emedicine.medscape.com/article/1389981- overview – Xenobiotic-induced porphyria cutanea tarda is the only one I have personally come across: http://emedicine.medscape.com/article/1103643-overview
  • 8. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Fetal Hb has a higher affinity for O2 than normal adult Hb – lower oxygen delivery to the tissues compared with adults
  • 9. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves
  • 10. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves 2,3-DPG = 2,3-diphosphoglycerate • Remember: • Left shift = less oxygen to the tissues = tissue hypoxia • Right shift = more oxygen to the tissues
  • 11. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Common and important toxicological situations affecting the O2Hb dissociation curve include: – Oxidative attack on erythrocytes and methemoglobinemias – Formation of sulfhemaglobin – Carbon monoxide
  • 12. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – Common cause of toxicological insult to the erythron – The presence of Fe in the Fe2+ reduction state is critical for normal O2 carrying capacity – Any oxidizing agent has the capacity to produce metHb by oxidizing Hb Fe2+ to Hb Fe3+ (ferrous  ferric)
  • 13. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – The critical effect of metHb is decreased tissue oxygen supply (i.e. tissue hypoxia) – MetHb cannot bind oxygen – The presence of metHb results in a left shift of the O2Hb dissociation curve, further exacerbating tissue hypoxia
  • 14. • Blood and mucous membranes are discolored brown (“muddy”) • Blood color change does not reverse (or reverses slowly) with exposure to oxygen (i.e. bubbling oxygen through tube of blood)
  • 15.
  • 16.
  • 17. Hemolysis and other signs of oxidative erythrocyte injury are commonly present (e.g. Heinz bodies, intravascular hemolysis)
  • 18. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – Note: Rodents are notoriously resistant to oxidative damage to the erythron and the formation of metHb – Note: Routine rodent studies alone may not detect the propensity for metHb formation and/or oxidative damage to the erythron – Note: Children under 4 years of age are more susceptible to oxidative damage to the erythron – Note: Cats are notoriously susceptible to oxidative damage to the erythron
  • 19. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – Note: in some human subpopulations glucose-6- phosphate dehydrogenase deficiency common (typically people of African, Middle Eastern and South Asian descent – protective adaptation to endemic malaria). These subpopulations are highly susceptible to oxidative assault on the erythron
  • 20.
  • 21. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – Note: Persons with pyruvate kinase deficiency are highly susceptible to oxidative damage to the erythron (lower energy generation  lower capacity to recycle GSH) • Also increases 2,3-bisphosphoglycerate (2,3 BPG)  right shift of the O2Hb dissociation curve  increased tissue oxygenation  individuals with PK deficiency may have a greater capacity for physical activity than others with similarly low hemoglobin levels. – Note: Persons with cytochrome b5 reductase deficiency are highly susceptible to oxidative damage to the erythron (reduced capacity to reverse metHb)
  • 22. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Methemoglobinemia – Note: Any organo-amine compound should be suspected of being a cause of oxidative damage to the erythron until proven otherwise – Note: any nitrite or nitrate compound (or compounds that are metabolized to a nitrite or a nitrate) are similarly suspect – Note: chromates are also similarly suspect – Note: Halogenated benzenes are also similarly suspect
  • 23. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Sulfhemoglobinemia – Due to the formation of ferric sulfide in Hb – Cannot be reversed metabolically – requires the replacement of affected erythrocytes – Produces a right shift of the O2Hb dissociation curve • Question: does this make tissue oxygenation better or worse?
  • 24. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • Sulfhemoglobinemia – Usually drug induced • Drugs associated with sulfhemoglobinemia include acetanilid, phenacetin, nitrates, trinitrotoluene and sulfur compounds (mainly sulphonamides, sulfasalazine) – Occupational exposure to sulfur compounds is another potential cause – > 0.5 g% sulfHb is abnormal
  • 25.
  • 26.
  • 27. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • CO-Hb; carbon monoxide poisoning; carboxy-Hb – Can occur due to either inhalation of CO (notably products of incomplete combustion) or xenobiotics that are metabolized to CO (common example is methylene chloride) – Hemoglobin binds to carbon monoxide preferentially compared to oxygen (approx 240:1) – COHb will not release the carbon monoxide, and therefore hemoglobin will not be available to transport oxygen from the lungs to the rest of the body
  • 28. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • CO-Hb; carbon monoxide poisoning; carboxy-Hb – COHb has a half-life in the blood of 4 to 6 hours – T½ reduced by exposure to oxygen – COHb increases the risk of infarction (increased incidence of ischemic disease in users of methylene chloride) – Produces a left shift of the O2Hb dissociation curve • Question: does this make tissue oxygenation better or worse?
  • 29. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • CO-Hb; carbon monoxide poisoning; carboxy-Hb – Produces a distinctive “cherry red” discoloration of blood, tissues, skin – Skeletal muscle is notably bright red due to the formation of carboxymyoglobin (used commercially to keep meat red and more attractive) – Persons who have died from CO poisoning are described as looking rosy cheeked and healthy (cherry red means dead)
  • 30. Conditions Affecting Oxygen Carrying Capacity: Oxygen Hb Dissociation Curves • CO-Hb; carbon monoxide poisoning; carboxy-Hb – Important issues: • Samples must be collected in air-tight tubes • Samples must be analyzed quickly otherwise falsely low levels of COHb may be detected • “Cherry red” discoloration of blood, skin, tissues etc. fades with time – important diagnostically • Bubbling oxygen through a tube of blood will hasten the loss of discoloration – used diagnostically
  • 31.
  • 32.
  • 33.
  • 34.
  • 35. Basic Concepts of Erythrocyte Function: Iron Metabolism • Except for external blood loss, there is no normal mechanism for the excretion of iron; • Provided the enterothelium remains intact, iron absorption is highly regulated; • Under normal circumstances, there is little free iron present in plasma (total iron binding capacity is not saturated) • Transferrin is a gamma-globulin
  • 36. Basic Concepts of Erythrocyte Function: Iron Metabolism • A wide variety of divalent metals compete with Fe2+ for uptake by DMT-1 (notably Cd2+, Pb2+); • The pH of the small intestine favors the formation of Fe3+ (mostly insoluble) which must be reduced by Dcytb to Fe2+ (soluble) for absorption to occur.
  • 37. Basic Concepts of Erythrocyte Function: Iron Metabolism • Hepcidin is the key hormone regulating Fe uptake from the GI; • Increased hepcidin occurs in a wide variety of chronic disease states (carcinogenesis) or inflammatory diseases leading to “anemia of chronic disease.” • Anemia of chronic disease is a common finding in chronic toxicology studies.
  • 38. Measures of Iron Status: Serum Iron • Measures the amount of iron bound to transferrin in the serum • Unreliable as a measure of total body iron stores • Can be reported as a % of total iron binding capacity (see later)
  • 39. Measures of Iron Status: Serum Iron • Conditions associated with low SI – Iron deficiency – Acute and chronic inflammatory processes/disease (anemia of chronic disease, anemia of inflammatory disease) – Hypoproteinemia (notably advanced liver disease)s – Hypothyroidism – Renal disease
  • 40. Measures of Iron Status: Serum Iron • Conditions associated with high SI – Hemolytic anemia (due to release of Fe from destroyed erythrocytes) – Sampling error resulting in hemolysis – Excessive glucocorticoids in some species (e.g. Cushing’s disease) – Iron overload • Acquired – Fe overload (Fe poisoning, excessive transfusions etc.) • Hereditary – Non-regenerative anemias (decreased Fe utilization)
  • 41. Measures of Iron Status: Serum Total Iron Binding Capacity • TIBC is an indirect measure of how much Fe the transferring present in serum will bind • Under normal conditions, about ⅓ of transferring binding sites are occupied under normal conditions – serum transferrin is not saturated under normal conditions • The difference between TIBC and SI is the amount of available Fe-binding capacity = unbound iron-binding capacity
  • 42. Measures of Iron Status: Serum Total Iron Binding Capacity • TIBC is increased in Fe deficiency in most species • TIBC is reduced (or even saturated [i.e. UIBC = 0]) in: – Fe poisoning – Intravascular hemolysis – Sampling error (hemolysis)
  • 43. Measures of Iron Status: Ferritin • Ferritin represent the labile (i.e. rapidly available) storage form of Fe • Small amounts of ferritin are normally present in the circulation as part of normal Fe homeostasis • Serum ferritin is decreased during iron deficiency
  • 44. Measures of Iron Status: Ferritin • Serum ferritin is increased during: – Hemolytic anemia – Iron overload – Acute and chronic inflammation – Liver disease – Neoplasia (notably lymphoma) – Malnutrition
  • 45. Common Causes of Disruptions of Iron Status in Repeated Dose Toxicology Studies • Iron deficiency and/or reduced iron uptake – More likely to be seen in chronic studies – Early stages may occasionally be seen in sub-chronic studies – In rodent studies, the animals are relatively young at the start of the study and are still rapidly growing (increased iron requirement + reduce capacity to absorb it from the GI + higher Hb turnover associated with switch from HbF to HbA) – Iron deficiencies can also can result when high concentrations of the test article are used in the diet – dietary dilution of essential minerals
  • 46. Common Causes of Disruptions of Iron Status in Repeated Dose Toxicology Studies • Iron deficiency and/or reduced iron uptake – Test article either inhibits or is a competitive substrate for enterothelial DMT-1 (typically other divalent metals) or Dcytb – Test article is an inhibitor of or competitor ferroportin – Test article reduced dietary iron bioavailability (binding in gut  insoluble) e.g. starches, tanins, phytates, vit. C, etc..
  • 47. Common Causes of Disruptions of Iron Status in Repeated Dose Toxicology Studies • Chronic disease states, notably neoplasia (increased hepcidin) • Significant inflammatory diseases (acute or chronic; increased hepcidin) • Hemolysis (error or due to toxicological effects) • Severe liver disease
  • 48. Erythrokinetics Essential for RBC production: • Iron • Vitamin B12 (cobalamin) • Folic Acid
  • 49.
  • 50. Erythrokinetics • The cell is released from the bone marrow as a reticulocyte – Circulating red blood cells are ~1% reticulocytes – After 1–2 days these ultimately become "erythrocytes" or mature red blood cells Question: what does it mean if you have an increased % of reticulocytes in the peripheral blood? Question: what does it mean if you have an increased % of normoblasts or nucleated RBCs in the peripheral blood?
  • 51.
  • 52.
  • 53. Erythrokinetics • The following characteristics can be seen changing in the erythrocytes when they are maturing: – They show a reduction in the cell size; – The cytoplasmic matrix increases in amount; – Staining (Wright’s stain) reaction of the cytoplasm changes from blue to pinkish red (this is because of the decrease in the amount of RNA and DNA); – Initially the nucleus was large in size and contained open chromatin. But with the maturation of RBC's the size of the nucleus decreases and finally disappears with the condensation of the chromatin material. Question: what does it mean if you have an increase in the number of RBCs in the peripheral circulation that stain blue (technical term = polychromasia or polychromatophilia)?
  • 54.
  • 55. Erythrokinetics Question: what does it mean if you have an increase in variation of erythrocyte size in peripheral blood (technical term = anisocytosis)?
  • 56.
  • 57. Erythrokinetics • Lifespan of an RBC in peripheral blood is species specific – in the range of 70 – 150 days in mammals depending on species; 35 days or so in birds • Eryptosis (RBC programmed cell death) – Form of apoptosis – Process makes the RBC prone to the extravascular pathway of erythrocyte destruction (phagocytosis by the reticuloendothelial systems of the liver, spleen and bone marrow [predominantly the red pulp of the spleen]) – Normally eryptosis and erthyropoesis exist in balance
  • 58. Erythrokinetics • Two pathways for RBC destruction: – Extravascular pathway (predominantly in the spleen, but also bone marrow and liver) – Intravascular pathway (i.e. lyse within the circulation)
  • 59. The anatomic structure of the spleen is ideal for testing the metabolic machinery and pliability of the red blood cells. Within the splenic pulp, red blood cells are concentrated and their intracellular metabolic pathways stressed. Following this, red blood cells must pass through 2- to 5-µm pores to enter the sinusoidal system. Unusually rigid cells or a cell containing inclusion bodies will be unable to pass this test and will be destroyed by sinusoidal reticuloendothelial cells.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65. Regulation of Erythropoesis EPO is produced in the juxtaglomerular apparatus of the kidney
  • 66. Evaluation of the Erythron: Indicators of the Circulating RBC Mass • Endpoints that are commonly used are: – Hematocrit (= packed cell volume = PCV) – Hemoglobin concentration of peripheral blood – RBC count
  • 67. Evaluation of the Erythron: Hematocrit (Packed Cell Volume = PCV)
  • 68. Evaluation of the Erythron: Hematocrit (=HCT=Packed Cell Volume = PCV) • HCT measured by centrifugation is a very accurate measure (± 1%) • Most commonly HCT is a calculated value from automated cell counters where HCT% = RBC/ul x mean corpuscular volume (fL) – Calculated HCT has a higher level of error – Cell counter MUST be calibrated to the species being examined – Birds have eliptical nucleated RBCs which interferes with this method
  • 69. Evaluation of the Erythron: Hematocrit (=HCT=Packed Cell Volume = PCV) • Typically plasma protein concentration by refractometry is measured at the same time • Typically the plasma color is examined (red for hemolysis, yellow of icterus/jaundice, lipidemia = pink and opaque)
  • 70.
  • 71. Evaluation of the Erythron: Hb Concentration • Provides the most direct measurement of the oxygen transport capacity of blood • Value should be ~ ⅓ of the HCT if RBCs are of normal size • Typically a colorimetric measurement • Must be corrected if Heinz bodies, hemolysis, or lipidemia is present • Major advantage over HCT is it allows calculation of the MCH and MCHC
  • 72. Evaluation of the Erythron: RBC Count • Automated machine counting is reasonably accurate if appropriately calibrated (except for birds) • Manual hemocytometer counts have a large error and are of little value except in birds • Major value of RBC count is that it allows calculation of the MCV and MCH (see below)
  • 73. Evaluation of the Erythron: RBC Count • Low values occur in anemia • High values occur in polycythemia (or blood doping) • Spuriously high values occur with dehydration and excitement in species with a contractile spleen (notably horses)
  • 74. Evaluation of the Erythron: Factors Affecting HCT, Hb, RBC • Low values occur in anemia • High values occur in polycythemia (or blood doping) • Spuriously high values occur with dehydration and excitement in species with a contractile spleen (notably horses) • Overhydration will result in spuriously low values • Fluid shifts (e.g. shock) can cause spurious values
  • 75. Evaluation of the Erythron: Factors Affecting HCT, Hb, RBC • The hydration/intravascular volume status of the animal must be determined in order to accurately interpret HCT, Hb and RBC! • How do you do this? – Total serum or plasma protein (serum or plasma specific gravity) in combination with the albumen:globulin ratio (A:G) is a useful quick guide – If the TP and plasma albumen are increased (in proportion) and the A:G ratio remains within the normal range, this is an indicator of dehydration (particularly if combined with an increased HCT HB & RBC) Why?
  • 76. Evaluation of the Erythron: Factors Affecting HCT, Hb, RBC • If both the TP and A:G are within the normal range and the HCT Hb & RBC are low, what does this suggest? • If the TP and A:G ratio are within the normal range and the HCT Hb & RBC are high, what does this suggest?
  • 77. Evaluation of the Erythron: RBC Indices Used in the Classification of Anemia • Mean corpuscular volume (MCV) = average RBC volume in fL • Mean corpuscular hemoglobin (MCH) = average mass of Hb present per RBC in pg • Mean corpuscular hemoglobin concentration (MCHC) = average concentration of Hb in RBC in g/100 mL of RBCs • Red cell distribution width = coefficient of variation of the RBC volume distribution
  • 78. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Can be a calculated value or determined by an automated cell counter – Calculate by dividing the HCT by the RBC count and converting to fL
  • 79. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Common causes of increased MCV (macrocytosis) – Reticulocytosis – Why? – Anything that inhibits nucleic acid synthesis and inhibits cell division i.e. reduced number of cell divisions during RBC ontogeny in the bone marrow. Commonly B12 deficiency • B12 deficiency is classically macrocytic and hypochromic (see later) – Anything that delays RBC maturation – Why? – Genetics – must make sure you are using the correct normal control values for the given strain – Spurious – RBC agglutination will result in falsely high MCV values
  • 80. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Common causes of increased MCV (macrocytosis) – Megaloblastic anemia, the most common cause of macrocytic anemia, is due to a deficiency of either vitamin B12, folic acid, or both – Pernicious anemia is caused by a lack of intrinsic factor, which is required to absorb vitamin B12 from food. A lack of intrinsic factor may arise from an autoimmune condition targeting the parietal cells (atrophic gastritis) that produce intrinsic factor or against intrinsic factor itself. These lead to poor absorption of vitamin B12. Alcoholism is a major cause of B12 malabsorption – Macrocytic anemia can also be caused by damage to the stomach (reduced B12 and folate absorption) – Hypothyroidism – Methotrexate, zidovudine, and other drugs may inhibit DNA replication.
  • 81. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Common causes of increased MCV (macrocytosis) – Macrocytic anemia can be further divided into "megaloblastic anemia" or "nonmegaloblastic macrocytic anemia". – The cause of megaloblastic anemia is primarily a failure of DNA synthesis with preserved RNA synthesis, which results in restricted cell division of the progenitor cells. The megaloblastic anemias often present with neutrophil hypersegmentation (six to 10 lobes). – The nonmegaloblastic macrocytic anemias have different etiologies (i.e. unimpaired DNA globin synthesis,) which occur, for example, in alcoholism.
  • 82. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Immature animals of most species have small RBCs and lower normal MCV values – must use the correct normal range for the species, strain and age group! • Causes of reduced MCV (microcytosis) • Iron deficiency is a classical cause of microcytosis – due to an additional round of cell division required to reach the critical cytoplasmic concentration of Hb necessary to stop further DNA synthesis and cell division of RBC precursors. Typically Fe deficiency anemias are microcytic hypochromic anemais
  • 83. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Causes of reduced MCV (microcytosis) – Heme synthesis defect • Iron deficiency anemia • Anemia of chronic disease (more commonly presenting as normocytic anemia) – Globin synthesis defect • Alpha-, and beta-thalassemia • HbE syndrome • HbC syndrome • Various other unstable hemoglobin diseases
  • 84. Evaluation of the Erythron: Mean Corpuscular Volume (MCV) • Normocytic anemias – Normocytic anemia occurs when the overall hemoglobin levels are decreased, but the red blood cell size (mean corpuscular volume) remains normal. – Causes include: • Acute blood loss • Anemia of chronic disease • Aplastic anemia (bone marrow failure) • Hemolytic anemia
  • 85.
  • 86. Evaluation of the Erythron: Mean Corpuscular Hb (MCH) • MCH = Hb ÷ RBC count • Generally factors affecting the MCV affect the MCH in a similar way – If the MCV is decreased (e.g. Fe deficiency), the MCH decreases since smaller RBCs contain less Hb • In general, the MCH is much less value than the other parameters in the classification of anemias • Interpretation of the Hb status of RBCs should be based on the MCHC rather than the MCV because the MCHC corrects for cell volume
  • 87. Evaluation of the Erythron: Mean Corpuscular Hb Concentration (MCHC) • MCHC = Hb ÷ HCT and then adjusted to g/dL • MCHC is the most accurate of the RBC indices because it does not require a RBC count • MCHC is the most useful parameter in classification of anemias • A true increase in MCHC does not normally occur – Increased MCHC is almost always spurious – due to hemolysis (calculation assumes that all Hb is contained within RBCs which is not true if hemolysis has occurred)
  • 88. Evaluation of the Erythron: Mean Corpuscular Hb Concentration (MCHC) • Reduced MCHC (Hypochromasia = hypochromia) – Occurs with reticulocytosis – reticulocytes are larger cells and contain less Hb, accordingly the Hb concentration is decreased – Iron deficiency due to reduced synthesis of Hb – Vitamin B6 deficiency – reduced synthesis of Hb – Lead exposure (inhibition of synthesis of Hb) – Drugs or xenobiotics that disrupt Hb synthesis
  • 89. Microcytic hypochromic anemia (Fe deficiency)
  • 90. Evaluation of the Erythron: RBC Distribution Width (RDW) • Coeficient of variation of the RBC volume distribution • RDW = SDMCV ÷ MCV x 100 • Index of the variation in size (i.e. aniocytosis) of RBCs • Anemias which are microcytic or macrocytic will have increased anioscytosis and an increased RDW • Significant reticulocytosis will result in an increased RDW and anisocytosis
  • 93. Peripheral Blood Smear – RBC Morphology • Stains – New methylene blue – acidic structures stain blue or purple (i.e. DNA, RNA, basophil granules) – Romanowsky stains (e.g. Wright’s, Diff-Quick) – acidic structures stain blue to purple, basic groups stain red (protein, eosinophil granules)
  • 94. Peripheral Blood Smear – RBC Morphology • Rouleaux formation – RBCs for stacks – Presence indicates an alteration of RBC surface charge (zeta potential) – Interpretation depends on the species • Horses normally have some Rouleaux formation in health – Rouleaux formation correlates with the RBC sedimentation rate i.e. protein coating of the surface of RBCs (e.g. fibrin during inflammatory processes, increased globulins, multiple myeloma)  increased ESR + increased Rouleaux formation
  • 95.
  • 96. Peripheral Blood Smear – RBC Morphology • Agglutination – Grape-like congregations of RBCs due to the presence of a cross-linking antibody (typically anti RBC IgM) – Important in toxicology because there are numerous xenobiotics that act as haptens on the surface of RBCs and generate an autoimmune anemia
  • 97.
  • 98. Peripheral Blood Smear – RBC Morphology • Spherocytes – Associated with immune mediated anemias – an important biomarker of extravascular immune-mediated RBC destruction – Result of phagocytosis of antigens on the surface of RBCs – Can result from phagocytosis of Heinz bodies (areas of oxidative precipitation of Hb in the erythrocyte – biomarker of oxidative damage to Hb) – Rarely, can result of changes to cell membrane compositon (acquired or hereditary)
  • 99.
  • 100. Peripheral Blood Smear – RBC Morphology • Polychromatophilia – Cells have a light blue-gray color when stained with a Wright’s stain – Classical feature of increased numbers of immature peripheral RBCs in the peripheral blood i.e. accelerated release of RBCs from the bone marrow – Classical characteristic feature of reticulocytes i.e. reticulocytosis is described as macrocytic, polychromasia and polychromatophilic..
  • 101.
  • 102. Peripheral Blood Smear – RBC Morphology • Poikilocytosis – General term for abnormally shaped RBCs – Can be spurious due to storage of sample before analysis – Can be normal in some species and at some stages of development e.g. switching from fetal to adult Hb – Indicate trauma to the RBC cell membrane due to • Turbulent blood flow • Intravascular fibrin (microangiopathic effects) – Specific types of poikilocytes can be associated with particular diseases e.g. acanthocytes are associated with particular types of liver diseases
  • 103. Acanthocytosis Typical response to listening to Barry Manilow music…..
  • 104. Peripheral Blood Smear – RBC Morphology • Echinocytosis – Form of poikiloctyes – Can be due to artifact – Can be due to xenobiotic exposure, particularly if effected blood electrolytes or membrane electrolyte transport or osmotic effects
  • 105.
  • 106. Peripheral Blood Smear – RBC Morphology • Hemlet cells (keratocytes) – Biomarker of oxidative damage to RBCs – Develop due to rupturing of a cell membrane vesicle or membrane blebs – Can also be produced by microangiopathic processes (see schistocytes below)
  • 107. Peripheral Blood Smear – RBC Morphology • Schistocyte – Irregular RBC fragments due to cutting of the RBC into pieces by intravascular fibrin deposits
  • 108.
  • 109. Peripheral Blood Smear – RBC Morphology • Basophilic stippling – Due to residual clumps of RNA, or precipitated ribosomes or mitochondria in RBCs – A characteristic of lead exposure (rare finding) – typically there is basophilic stippling but NO polychromasia (why?) – Can occur during regenerative anemias in conjunction with polychromasia – Also seen with severe burns, some xenobiotics, septicemia
  • 110.
  • 111. Peripheral Blood Smear – RBC Morphology • Heinz bodies – A classical biomarker of oxidative damage to the erythron – Due to denatured Hb – RBCs prone to hemolysis
  • 112. Peripheral Blood Smear – RBC Morphology • Metarubricyte – Term refers to the presence of any form of nucleated RBC in the peripheral blood – Indicates highly increased demand for RBCs and may be appropriate (e.g. response to increased erythropoesis in responsive anemias) or inappropriate (e.g. due to lead poisoning, Fe deficiency, Cu deficiency etc.)
  • 113. Bone Marrow Evaluation • Parameters: – Cellularity – Number of megakaryocytes (platelet precursors) – Myeloid: erythroid ratio – Morphology
  • 114.
  • 115. Bone Marrow Evaluation • M:E ratio – Usually used to determine the efficiency of the response to anemia – Should be interpreted with the WBC count i.e. if the WBC count is normal and the M:E is decreased it is indicative of an increased production of RBCs and a normal response to anemia – A high M:E ratio in the presence of a normal WBC count and anemia indicates a problem with RBC production
  • 116.
  • 117. Regenerative Vs Non-Regenerative Anemias • Characteristics of regenerative anemias = evidence of increased production of RBCs – Polychromasia – Why? – Reticulocytosis – Why? – Anisocytosis + increased RDW – Why? – Increased MCV + macrocytosis – Why? – Basophilic stippling – Why? – Hypercellular bone marrow with a reduced M:E – Why? – Are all of the above responses appropriate and if so, why?
  • 118. Regenerative Vs Non-Regenerative Anemias • Characteristics of regenerative anemias = evidence of increased production of RBCs – Polychromasia – Why? – Reticulocytosis – Why? – Anisocytosis + increased RDW – Why? – Increased MCV + macrocytosis – Why? – Basophilic stippling – Why? – Hypercellular bone marrow with a reduced M:E – Why? – Are all of the above responses appropriate and if so, why?
  • 119. Regenerative Vs Non-Regenerative Anemias • Characteristics of regenerative anemias – Tend to be non-chronic – Internal blood loss and hemolytic anemias tend to respond more rapidly than external blood loss anemias (why?)
  • 120. Regenerative Vs Non-Regenerative Anemias • Characteristics of non-regenerative anemias – Tend to chronic – why? – By definition there is an inadequate bone marrow response which may be due to: • Not enough time – RBC destruction is faster than RBC production • Inadequate precursor materials (e.g. Fe, B12, B6 etc.) • Increased hepcidin due to inflammatory diseases (decreased Fe) • Renal disease – not enough erythropoeitin • Bone marrow destruction (neoplasia, infections)
  • 121. Case Studya1 • Following data (group mean from treatment group) was from day 45 of a 90 day study in rats: Parameter Value High or low relative to normal Range, Pre- exposure measurements and control Group (all changes statistically significant) HCT 13 % Low Hb 3.9 g/dL Low RBC 1.59 x 106/ul Low MCV 81 fL High MCH 24.5 pg MCHC 30.0 % Low Reticulocytes 16.5 % High 264 x 103/ul Nucleated RBCs 3 per 100 WBC High Total protein 3.8 g/dL Low Albumin 1.8 g/dL Low A:G 0.90 Normal RBC morphology: anisocytosis, polychromasia
  • 122. Case Studya1 • Following data (group mean from treatment group) was from day 45 of a 90 day study in rats: Parameter Value High or Low Compared With Normal Range and Control Group Platelets 653 x 103/uL High WBC 17.5 x 103/uL High WBC morphology is normal 1.59 x 106/ul Low
  • 123. Case Study 1 • Answer the following questions – What is the type of erythron problem present? – What other problems are present? – What is the likely mechanism involved? – Is the problem being reversed/repaired? – What would you hope to see by day 90 of the study? – What would you expect to see 30 days following the cessation of exposure to the test article? • Why? • What conditions might have to happen for any change to occur? • What conditions might prevent any putative recovery?
  • 124. Case Studya2 • Following data (group mean from treatment group) was from day 90 of a rat study Parameter Value High or low relative to normal Range, Pre- exposure measurements and control Group (all changes statistically significant) HCT 15% Low Hb 4.4 g/dL Low RBC 1.79 x 106/ul Low MCV 84 fL High MCH 24.6 pg MCHC 29.3 % Low Reticulocytes 24 % High 430 x 103/ul Nucleated RBCs 6 per 100 WBC High Total protein 6.5 g/dL Normal Albumin 2.9 g/dL Normal A:G 0.81 Normal RBC morphology: anisocytosis, polychromasia, spherocytosis,
  • 125. Case Study 2 • Answer the following questions – What is the type of erythron problem present? – What other problems are present? – What is the likely mechanism involved? – Is the problem being reversed/repaired? – What would you hope to see by day 90 of the study? – What would you expect to see 30 days following the cessation of exposure to the test article? • Why? • What conditions might have to happen for any change to occur? • What conditions might prevent any putative recovery?
  • 126. Case Study 3 • Following data (group mean from a treatment group) was from day 3 of a 90 day study in cats. Some deaths have occurred in this exposed group Parameter Value High or low relative to normal Range, Pre- exposure measurements and control Group (all changes statistically significant) HCT 25.2% Low Hb 11.2 g/dL Normal RBC 5.5 x 106/ul Low MCV 45 fL Normal MCH 20 pg MCHC 44 % High Total protein 8.5 High Albumin 3.9 g/dL Normal A:G 0.85 Normal RBC morphology: excessive Heinz bodies present Additional comments: serum is red tinged, blood was chocolate colored, urine was dark brown
  • 127. Case Study 3 • Answer the following questions – What is the type of erythron problem present? – What other problems are present? – What is the likely mechanism involved? – Is the problem being reversed/repaired? – What other problems might occur with this? – What would you hope to see by day 90 of the study? – What would you expect to see 30 days following the cessation of exposure to the test article? • Why? • What conditions might have to happen for any change to occur? • What conditions might prevent any putative recovery?
  • 128. Case Studya4 • Following data (group mean from treatment group) was from day 90 of a 90 day study in rats: Parameter Value High or low relative to normal Range, Pre- exposure measurements and control Group (all changes statistically significant) HCT 12.8 % Low Hb 4.0 g/dL Low RBC 2.25 x 106/ul Low MCV 56.9 fL High MCH 17.8 pg Low MCHC 31.3 % Low Reticulocytes 0% Low Nucleated RBCs 0 per 100 WBC High RBC morphology: hypochromasia
  • 129. Case Study 4 • Answer the following questions – What is the type of erythron problem present? – What other problems are present? – What is the likely mechanism involved? – Is the problem being reversed/repaired? – What other problems might occur with this? – What would you hope to see by day 90 of the study? – What would you expect to see 30 days following the cessation of exposure to the test article? • Why? • What conditions might have to happen for any change to occur? • What conditions might prevent any putative recovery?
  • 130. Case Studya5 • Following data (group mean from treatment group) was from day 90 of a 90 day study in rats: Parameter Value High or low relative to normal Range, Pre- exposure measurements and control Group (all changes statistically significant) HCT 26 % Low Hb 8.8 g/dL Low RBC 5.23 x 106/ul Low MCV 49.7 fL Normal MCH 16.8 pg MCHC 33.8 % Normal Reticulocytes 0.1 % Normal 52 x 103/ul Nucleated RBCs 0 per 100 WBC High Total protein 9.3 g/dL High Albumin 1.9 g/dL Low A:G 0.0.26 low RBC morphology: Normal
  • 131. Case Study 5 • Answer the following questions – What is the type of erythron problem present? – What other problems are present? – What is the likely mechanism involved? – Is the problem being reversed/repaired? – What other problems might occur with this? – What would you hope to see by day 90 of the study? – What would you expect to see 30 days following the cessation of exposure to the test article? • Why? • What conditions might have to happen for any change to occur? • What conditions might prevent any putative recovery?
  • 132. Case Study 1 • Regenerative blood loss anemia • Macrocytic hypochromic anemia with polychromasia and reticulocytosis • Loss of total protein due to hemorrhage + subsequent fluid shifts into the vascular compartment
  • 133. Case Study 2 • Macrocytic hypochromic regenerative hemolytic anemia with evidence of extravascular erythrophagocytosis • Autoimmune mediated anemia
  • 134. Case Study 3 • Oxidative intravascular hemolytic anemia + met Hb
  • 135. Case Study 4 • Microcytic, hypochromic non-regenerative anemia • Fe deficiency
  • 136. Case Study 5 • Normocytic, normochromic anemia + hyperproteinemia due increased globulins + decreased albumen • Chronic inflammatory disease

Notas do Editor

  1. ----- Meeting Notes (16/11/12 23:57) -----Case 1: External blood loss anemia
  2. ----- Meeting Notes (16/11/12 23:57) -----Case 1: External blood loss anemia